Literature DB >> 354676

Activation of radiosensitizers by hypoxic cells.

P L Olive, R E Durand.   

Abstract

Hypoxic cells can metabolize nitroheterocyclic compounds to produce toxic intermediates capable of affecting the survival of neighbouring oxygenated cells. Mutagenesis experiments with E. coli WP-2 343 (deficient in nitroreductase) indicated that reduction of nitroheterocyclics outside bacteria causes killing and mutations within bacteria, presumably due to the transfer of the "active" specie (s). Using animal tissue slices to reduce nitrofurans, cultured L-929 cells incubated under aerobic conditions were far more sensitive to the toxic and DNA damaging effects of these drugs. Transfer of the active species also occurs in a tissue-like environment in multicell spheroids where the presence of a hypoxic central core served to convert the nitroheterocyclics to intermediates which also damaged the neighbouring oxygenated cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 354676      PMCID: PMC2149417     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  8 in total

1.  Isolation of cell subpopulations from in vitro tumor models according to sedimentation velocity.

Authors:  R E Durand
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

2.  The effects of nitrobenzene derivatives on oxygen utilization and radiation response of an in vitro tumor model.

Authors:  J E Biaglow; R E Durand
Journal:  Radiat Res       Date:  1976-03       Impact factor: 2.841

3.  Metronidazole (Flagyl): iron catalysed reaction with sulphydryl groups and tumour radiosensitisation.

Authors:  R L Willson; A J Searle
Journal:  Nature       Date:  1975-06-05       Impact factor: 49.962

Review 4.  Chemical radiosensitization of hypoxic cells.

Authors:  G E Adams
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

5.  Letter: Radiation-induced single-strand breaks in DNA determined by rate of alkaline strand separation and hydroxylapatite chromatography: an alternative to velocity sedimentation.

Authors:  G Ahnström; K A Edvardsson
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1974-11

6.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

7.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection.

Authors:  B N Ames; W E Durston; E Yamasaki; F D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

8.  Cytotoxicity and DNA damage to mammalian cells by nitrofurans.

Authors:  P L Olive; D R McCalla
Journal:  Chem Biol Interact       Date:  1977-02       Impact factor: 5.192

  8 in total
  6 in total

1.  Effects of sensitizers on cell respiration: III. The effects of hypoxic cell radiosensitizers on oxidative metabolism and the radiation response of an in vitro tumour model.

Authors:  R E Durand; J E Biaglow; C L Greenstock
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 2.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 3.  Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).

Authors:  W A Denny; W R Wilson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

4.  Low concentrations of misonidazole counteract effects of extreme hypoxia on cells in S.

Authors:  E O Pettersen; T Lindmo
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

5.  Inhibition of DNA synthesis by nitroheterocycles. I. Correlation with half-wave reduction potential.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

6.  In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.

Authors:  R T Mulcahy; D W Siemann; R M Sutherland
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.